Colorectal Cancer Tumor Board - 5/14/2025

Wednesday, May 14, 2025, 3:30 PM - 4:30 PM PST, Cancer Center, Palo Alto, CA

This series discusses Colorectal Cancer patient cases to optimize and coordinate multidisciplinary care, practice evidence based care, adhere to national guidelines for care, coordinate novel protocols under study, and provides educational opportunities for faculty, residents and students.

Objective(s): 1 Formulate a comprehensive treatment plan for patients with advanced or complex colon and rectal cancers. 2 Incorporate multidisciplinary and cutting edge treatment options for advanced or complex colon and rectal cancers.
Location: Cancer Center
Specialties: Oncology, Surgery, Medical Oncology, Colorectal Surgery

Faculty Disclosures:
Arden Marie Morris, MD (Nothing to disclose - 06/04/2024)
George Albert Fisher, MD (Advisor-Hutchison MediPharma (Relationship has ended)|Advisor-Exelixis (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Peel Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca - 08/05/2024)
Erqi Liu Pollom, MD (Nothing to disclose - 07/09/2024)
Download Handout

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Formulate a comprehensive treatment plan for patients with advanced or complex colon and rectal cancers.
2. Incorporate multidisciplinary and cutting edge treatment options for advanced or complex colon and rectal cancers.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine (ABIM) MOC Credit 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery (ABS) CC Credit 
Successful completion of this CME activity which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. 

MOC Participation Threshold

Learner participates in verbal or chat-based case discussion/conversation as judged by a group leader or observer.

Cancellation Policy
Live Activities: Cancellations received in writing no less than 20 days before the course will be refunded. No refunds will be made on cancellations received after that date. Self-paced Activities: No refunds will be made on cancellation requests after a learner accesses any part of the course content. Any cancellations refunded will less a 20% administrative fee. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
<Insert here in APA style format>

For activity related questions, please contact
     Name:
     Title:
     Email: 

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Date	Empty Column	Title
5/14/2025 3:30:00 PM	Colorectal Cancer Tumor Board - 5/14/2025 5/14/2025 3:30:00 PM 5/14/2025 4:30:00 PM 6 Cancer Center False MM/DD/YYYY	Colorectal Cancer Tumor Board - 5/14/2025 This series discusses Colorectal Cancer patient cases to optimize and coordinate multidisciplinary care, practice evidence based care, adhere to national guidelines for care, coordinate novel protocols under study, and provides educational opportunities for faculty, residents and students. Objective(s): 1 Formulate a comprehensive treatment plan for patients with advanced or complex colon and rectal cancers. 2 Incorporate multidisciplinary and cutting edge treatment options for advanced or complex colon and rectal cancers. Location: Cancer Center Specialties: Oncology, Surgery, Medical Oncology, Colorectal Surgery Faculty Disclosures: Arden Marie Morris, MD (Nothing to disclose - 06/04/2024) George Albert Fisher, MD (Advisor-Hutchison MediPharma (Relationship has ended)|Advisor-Exelixis (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Peel Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca - 08/05/2024) Erqi Liu Pollom, MD (Nothing to disclose - 07/09/2024) Download Handout Location: Cancer Center Specialties: Colorectal Surgery, Medical Oncology, Oncology, Surgery